Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report.
JTO clinical and research reports, vol.3, no.6, pp.100330, 2022 (Refereed Journals of Other Institutions)
Article / Article
Title of Journal :
JTO clinical and research reports